Who Paid My Doc Search
Menu
Product Program year 2025 Source: CMS Open Payments

Hercessi

Drug Oncology - HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]

NDC 69448-015-05

Open in the dashboard

General payments

$16,955

46 payments

Research payments

$0

0 payments

Through program year 2025, $16,955 in general payments and $0 in research payments were reported against Hercessi (Oncology - HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $16,955 46

Breakdown

Who paid General payments · program year 2025
  1. Accord Healthcare, Inc. $16,955 46 payments
Top recipients General payments · program year 2025
  1. Duke University Hospital Teaching hospital · NC $10,800 64% · 3 payments
  2. Alexandra Thomas Hematology & Oncology · Winston Salem, NC $4,350 26% · 4 payments
  3. University Of Wi Hospitals & Clinics Teaching hospital · WI $1,000 6% · 1 payment
  4. Mark Marinella Medical Oncology · Kettering, OH $34 <1% · 1 payment
  5. Gregory Rasp Radiation Oncology · Englewood, OH $34 <1% · 1 payment

The top 5 of 39 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Hematology & Oncology Internal Medicine $4,836 94% · 23 practitioners
  2. Medical Oncology Internal Medicine $81 2% · 3 practitioners
  3. Radiation Oncology Radiology $70 1% · 3 practitioners
  4. Physician Assistant $63 1% · 3 practitioners
  5. Nurse Practitioner $25 <1% · 1 practitioner

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. North Carolina $15,300 90% · 9 recipients
  2. Wisconsin $1,000 6% · 1 recipient
  3. Ohio $125 <1% · 4 recipients
  4. Washington $101 <1% · 5 recipients
  5. California $96 <1% · 5 recipients

The top 5 of 14 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Records

46 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record